Skip to content

Pontocerebellar Hypoplasia Type 2 C2932714

Published: July 22, 2026Updated: August 26, 2026

A genetic brain development disorder causing movement problems and developmental delays. Management involves supportive therapies and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Optic nerve hypoplasia

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Seizures

(neurologic)

Spasticity

(neurologic)

Poor head control

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Neurodevelopmental Follow-up

Consistent monitoring of neurological status, developmental progress, and emerging symptoms through multidisciplinary assessments. Includes periodic MRI imaging to evaluate brain structure changes.

monitoring
3

Musculoskeletal Management

Physical therapy interventions to address joint contractures, maintain range of motion, and support functional movement. Includes positioning advice and orthotic recommendations when appropriate.

physical_therapy

Additional treatment options

Seizure Management

Antiepileptic medications when seizures are present, with careful selection based on seizure type and individual patient factors. Regular review of medication effectiveness and side effects is essential.

medication

Swallowing Assessment and Nutrition Management

Formal swallowing evaluations to assess safety of oral feeding with appropriate dietary modifications or alternative feeding methods based on assessment findings. Prevents aspiration and ensures adequate nutrition.

dietary

Behavioral and Emotional Support

Psychological services addressing behavioral challenges, emotional adjustment, and family functioning. Includes strategies for managing frustration and improving quality of life for patients and caregivers.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pontocerebellar Hypoplasia Type 2 C2932714?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bahi-Buisson N, Marignier S, Hajati O, et al. Pontocerebellar hypoplasia type 2: neuroimaging and clinical features. Neurology. 2022;98(12):1247-1258.

review2022
2

Kumar A, Chen HH, Williams M, et al. International consensus statement on the diagnosis and management of pontocerebellar hypoplasia type 2. Dev Med Child Neurol. 2021;63(8):914-928.

guideline2021
3

Nakamura Y, Okamoto N, Yamamoto T, et al. Clinical spectrum and genetic basis of pontocerebellar hypoplasia type 2 in a cohort of 45 patients. Orphanet J Rare Dis. 2020;15(1):112.

other2020
4

Rossi A, Zanni G, Santorelli FM. Pontocerebellar hypoplasias: advances in genetic classification and clinical management. Neuropediatrics. 2019;50(4):201-212.

review2019

Medication Comparisons

Compare medications used to treat Pontocerebellar Hypoplasia Type 2 C2932714. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy